We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Merck Licenses NanoBio Technology

News   Mar 29, 2014

 
Merck Licenses NanoBio Technology
 
 
Advertisement
 

RELATED ARTICLES

Human Cell “Membrane-on-Chip'” Helps Hunt for Drugs Against COVID-19

News

Researchers have created a human cell '"membrane on a chip" that allows continuous monitoring of how drugs and infectious agents interact with our cells. The device could soon be used to screen potential drug candidates against SARS-CoV-2.

READ MORE

Mutated Form of SARS-CoV-2 Is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

Safer and More Efficient Method To Deliver Gene Therapy

News

Madison researchers have developed a safer and more efficient way to deliver a promising new method for treating cancer and liver disorders and for vaccination.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE